Sökresultat

Filtyp

Din sökning på "what do you do on the dark web 【Visit Sig8.com】9ZP42K8.5R9I" gav 84427 sökträffar

Human and nature in symbiosis

In recent years, ‘ecosystem services’ has become an increasingly common concept within the research community, as well as in municipalities, public authorities and industry. In simple terms, ecosystem services can be described as the benefits humans gain from nature’s ecosystems, for example regarding the food we eat, the air we breathe, purification of the water we drink, the bioenergy we use to

https://www.lunduniversity.lu.se/article/human-and-nature-symbiosis - 2025-11-23

An Innovative Medicines Initiative Project for Precision Medicine in DKD

BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-¬¬year project (total budget 28

https://www.ludc.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2025-11-23

“Death receptors” – new markers for type 2 diabetes and cardiovascular disease

Researchers at Lund University in Sweden have found that the presence of death receptors in the blood can be used to directly measure the risk of developing cardiovascular diseases and type 2 diabetes. “We see that people with known risk factors such as high blood sugar and high blood fats also have heightened death receptor levels”, says Professor Jan Nilsson who led the study. Death receptors ar

https://www.ludc.lu.se/article/death-receptors-new-markers-type-2-diabetes-and-cardiovascular-disease - 2025-11-23

An Innovative Medicines Initiative Project for Precision Medicine in DKD

LAUNCH OF BEAt-DKD – 6 FEBRUARY 2017 BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch o

https://www.lunduniversity.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2025-11-23

Biological supercomputers to be powered by molecular motors

Crashing computers or smartphones - and security loopholes that allow hackers to steal millions of passwords - could be prevented if it were possible to design error-free software. To date, this is a problem that neither engineers nor current supercomputers have been able to solve. A major reason for this is the computing power required to verify large programs. Today’s computers use vast amounts

https://www.lunduniversity.lu.se/article/biological-supercomputers-be-powered-molecular-motors - 2025-11-23

Gut microbiome research indicates new bacteria and metformin associations

A large-scale faeces and blood sample study indicates strong associations between gut bacteria and metabolites in the blood. Among other findings, the research team behind the study has identified new associations between a common type 2 diabetes drug and the gut microbiome. The study was led by researchers at Uppsala University and Lund University. The role of the gut microbiome in disease and he

https://www.ludc.lu.se/article/gut-microbiome-research-indicates-new-bacteria-and-metformin-associations - 2025-11-23

Diabetes researcher Helena Elding Larsson wants to prevent type 1 diabetes from developing

Since Helena Elding Larsson began her career as a diabetes researcher and paediatrician, she has seen many improvements in the care of patients with diabetes. Her own research focuses on the prevention of the development of type 1 diabetes. Helena Elding Larsson is this year’s recipient of the Medeon stipend, and she will be speaking at the World Diabetes Day Skåne event, in Malmö on November 12th

https://www.ludc.lu.se/article/diabetes-researcher-helena-elding-larsson-wants-prevent-type-1-diabetes-developing - 2025-11-23

PAX5 – a gene strongly associated with impaired insulin secretion in type 2 diabetes

Researchers have identified 395 genes that are differently expressed in people with type 2 diabetes. One of the genes proved to be very strongly associated with impaired insulin secretion. Now, researchers want to investigate if it is possible to use the genetic CRISPR/Cas9 scissors to correct the gene’s activity. The research team’s scientific paper was published in the Journal of Clinical Invest

https://www.ludc.lu.se/article/pax5-gene-strongly-associated-impaired-insulin-secretion-type-2-diabetes - 2025-11-23

New method offers hope of fewer fractures

Thousands of people could be spared from a hip fracture each year if a new method to identify the risk of osteoporotic fractures were to be introduced in healthcare. This is the view of the researchers at Lund University in Sweden who are behind a new 3D-simulation method. The results were recently published in the Journal of Bone and Mineral Research. Osteoporosis causes 120,000 bone fractures in

https://www.lunduniversity.lu.se/article/new-method-offers-hope-fewer-fractures - 2025-11-24

Time to ring out the old year and ring in the new!

It is time to summarise 2021, a year in which nothing was the same as before, if a year can ever be like another. For me personally, it has been transformative to take over as vice-chancellor of Lund University together with a new management team: deputy vice-chancellor Lena Eskilsson and the five pro vice-chancellors Per Mickwitz, Kristina Eneroth, Ann-Kristin Wallengren, Jimmie Kristensson and V

https://www.staff.lu.se/article/time-ring-out-old-year-and-ring-new - 2025-11-24

Nerve cells could transform the treatment of Parkinson’s

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.lunduniversity.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2025-11-24

Alzheimer's disease is composed of four distinct subtypes

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals. The study was published in Nature Medicine. “In contrast to how we have so far interpreted the spread of tau in the

https://www.multipark.lu.se/article/alzheimers-disease-composed-four-distinct-subtypes - 2025-11-23

More nanotechnology for everyone as NanoLund makes new investment

Within the next few years, Lund Nano Lab will move into new premises in Science Village that are twice the current size. The new investment will provide unique opportunities for research and collaboration with the goal of improving conditions for human life and the climate through nanotechnology. “Now it’s really happening. We are using nanotechnology solutions in everyday life throughout society,

https://www.lunduniversity.lu.se/article/more-nanotechnology-everyone-nanolund-makes-new-investment - 2025-11-23

AI model from Lund University indicates four out of ten breast cancer patients could avoid axillary surgery

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information in mammograms and pinpoints with high accuracy the individual risk of metastasis in the armpit. A newly completed study shows that the model indicates that just over 40 per cent of today’s axillary surgery

https://www.medicine.lu.se/article/ai-model-lund-university-indicates-four-out-ten-breast-cancer-patients-could-avoid-axillary-surgery - 2025-11-23

Biomarker reveals inflammatory changes in the brain with Alzheimer’s disease

Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international collaboration including researchers at MultiPark, Lund University has made it possible to detect elevated levels of Galectin-3, a protein expressed in the immune cells inside the brain. The results were published in Acta N

https://www.multipark.lu.se/article/biomarker-reveals-inflammatory-changes-brain-alzheimers-disease - 2025-11-23

Nerve cells could transform the treatment of Parkinson’s

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2025-11-23

The innovation environment for customised stem cell treatments turns two

IndiCell, short for Individualized Cell Therapy, is a national initiative in Sweden to speed up the development of advanced therapies that can help treat or cure a range of diseases and medical conditions. The project, led by researchers at the Lund Stem Cell Center at Lund University, is now celebrating its second anniversary. Launched in 2021 with funding from Vinnova, the Swedish Innovation Age

https://www.stemcellcenter.lu.se/article/innovation-environment-customised-stem-cell-treatments-turns-two - 2025-11-23